Specified Drug Use-Results Survey on "ACOALAN for CAD "
Not Applicable
- Conditions
- Congenital antithrombin III deficiency (CAD)
- Registration Number
- JPRN-UMIN000050276
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
When the contract is not concluded When the number of contract cases has been reached If the administration start date is out of the contract period For already registered patients Patients used for diseases other than approved efficacy benefits
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety 1.Development of ADR/infectious diseases (type, incident rate, etc.) 2.Investigation of factors considered to affect safety 3.Status of serious adverse events Effectiveness 1.Effective rate 2.Examination of factors considered to affect the effectiveness
- Secondary Outcome Measures
Name Time Method